NETEC Resource Library

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Item

Click for External Resource*


Click to read full article*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Item Type

Publication

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Was this resource helpful?


Title

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Description

The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of adenoviral vector vaccines against coronavirus disease 2019 (Covid-19).

Date

2021-08-19

Citation

Bourguignon, Alex, Donald M. Arnold, Theodore E. Warkentin, James W. Smith, Tania Pannu, Jeffrey M. Shrum, Zainab A. A. Al Maqrashi, Anjali Shroff, Marie-Claude Lessard, Normand Blais, John G. Kelton, and Ishac Nazy. 2021. "Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia." New England Journal of Medicine 385 (8):720-8.

Accessibility

Free online on NEJM.

Collection